Eur Rev Med Pharmacol Sci 2010; 14 (1): 69-70

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand

F. Pandolfi*, D. Pitocco, R. Cianci, L. Mancini, G. Ghirlanda

Department of Internal Medicine, Catholic University of the Sacred Heart, Rome (Italy) Corresponding Author: Franco Pandolfi, MD; e-mail: pandolfi@rm.unicatt.it

To cite this article

F. Pandolfi*, D. Pitocco, R. Cianci, L. Mancini, G. Ghirlanda
Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand

Eur Rev Med Pharmacol Sci
Year: 2010
Vol. 14 - N. 1
Pages: 69-70

Keywords Related articles:

  1. The impact of biological agents interfering with receptor/ligand binding in the immune system
  2. The role of nuclear medicine in the diagnosis of spondylodiscitis
  3. Kidney vasculogenesis and angiogenesis: role of Vascular Endothelial Growth Factor
  4. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity
  5. Electroionotherapy in acute arthrorheumatic pain